Pegasys 135 micrograms solution for injection in pre-filled syringe

DRUG2 trials

Sponsors

Karolinska University Hospital, Region Sjaelland

Conditions

Colon cancerhepatitis D

Phase 2

Effect of low-dose Interferon-alfa2a on perioperative immune suppression

RecruitingCTIS2024-517619-65-00

Region SjaellandColon cancer

Start: 2023-08-28Target: 68Updated: 2026-01-20

Phase 3

Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Patients with Chronic hepatitis D

RecruitingCTIS2023-504414-29-00

Karolinska University Hospitalhepatitis D

Start: 2023-06-19Target: 400Updated: 2023-05-12